First-in-Class Oral IRF5 Degrader, KT-579, Demonstrates Significant Activity Alone or in the Presence of Background Therapies in Preclinical Lupus Models
American College of Rheumatology (ACR) 2026
Erik Corcoran, Emily Lurier, Jordan Leedberg, Yi Zhang, Chris Ho, Dapeng Chen, Revonda Mehovic, Rahul Karnik, Sarah Martinez, Susanne Breitkopf, Veronica Campbell